Evidence for bistable bacteria-neutrophil interaction and its clinical implications

Journal of Clinical Investigation

Volumn 122, Issue 8, 2012, Pages 3002-3011

  Malka, Roy ^a,d,e   Wolach, Baruch ^b   Gavrieli, Ronit ^b   Shochat, Eliezer ^c   Rom Kedar, Vered ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b MEIR MEDICAL CENTER   (Israel)

^c Pharma Research and Early Development   (Switzerland)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; GRANULOCYTE COLONY STIMULATING FACTOR;

ARTICLE; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIAL LOAD; BACTERIAL VIABILITY; CELL FUNCTION; HUMAN; INFECTION RISK; MATHEMATICAL MODEL; NEUTROPENIA; NEUTROPHIL; NEUTROPHIL COUNT; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; TREATMENT RESPONSE;

BACTERIA; BACTERIAL INFECTIONS; BACTERIAL PHYSIOLOGICAL PHENOMENA; BLOOD BACTERICIDAL ACTIVITY; HOST-PATHOGEN INTERACTIONS; HUMANS; NEOPLASMS; NEUTROPENIA; NEUTROPHILS; OXADIAZOLES; PHAGOCYTOSIS; STAPHYLOCOCCUS AUREUS;

EID: 84864742222     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI59832     Document Type: Article

References (35)

1. Crawford J, Dale DC, Lyman GH. Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management. Cancer. 2004;100(2):228-237. (Pubitemid 38063629)
2. WHO. ICD-10: International Statistical Classification of Diseases and Related Health Problems. 10th ed. Vol. 1. Geneva, Switzerland: World Health Organization; 1992.
3. Wolach B, et al. Chronic granulomatous disease in israel: clinical, functional and molecular studies of 38 patients. Clin Immunol. 2008;129(1):103-114.
4. van den Berg JM, et al. Chronic granulomatous disease: The european experience. PLoS One. 2009;4(4):e5234.
5. Kuijpers TW, et al. Natural history and early diagnosis of lad-1/variant syndrome. Blood. 2007;109(8):3529-3537. (Pubitemid 46572546)
6. Clawson CC, Repine JE. Quantitation of maximal bactericidal capability in human neutrophils. J Lab Clin Med. 1976;88(2):316-327.
7. Leijh PCJ, van den Barselaar MT, van Furth R. Kinetics of phagocytosis of Staphylococcus aureus and Escherichia coli by human granulocytes. Immunology. 1979;37(2):453-465. (Pubitemid 9229612)
8. Hammer MC, Baltch AL, Sutphen NT, Smith RP, Conroy JV. Pseudomonas aeruginosa: quantitation of maximum phagocytic and bactericidal capabilities of normal human granulocytes. J Lab Clin Med. 1981;98(6):938-948. (Pubitemid 12253337)
9. Li Y, Karlin A, Loike DJ, Silverstein CS. A critical concenration of neutrophils is required for effective bacterial killing in suspension. Proc Natl Acad Sci U S A. 2002;99(12):8289-8294. (Pubitemid 34651045)
10. Li Y, Karlin A, Loike DJ, Silverstein CS. Determination of the critical concentration of neutrophils required to block bacterial growth in tissues. J Exp Med. 2004;200(5):613-622. (Pubitemid 39258310)
11. Malka R, Shochat E, Rom-Kedar V. Bistability and bacterial infections. PLoS One. 2010;5(5):e10010.
12. Malka R, Rom-Kedar V. Bacteria-phagocytes dynamics, axiomatic modelling and mass-action kinetics. Math Biosci Eng. 2011;8(2):475-502.
13. Shochat E, Rom-Kedar V. Novel strategies for g-csf treatment of high- risk severe neutropenia suggested by mathematical modeling. Clin Cancer Res. 2008;14(20):6354-6363.
14. Werner AS, Cobbs CG, Kaye D, Hook EW. Studies on the bacteremia of bacterial endocarditis. JAMA. 1967;202(3):199-203.
15. La Scolea LJ Jr, Dryja D. Quantitation of bacteria in cerebrospinal fluid and blood of children with meningitis and its diagnostic significance. J Clin Microbiol. 1984;19(2):187-190. (Pubitemid 14183575)
16. Wain J, et al. Day quantitation of bacteria in bone marrow from patients with typhoid fever: relationship between counts and clinical features. J Clin Microbiol. 2001;39(4):1571-1576. (Pubitemid 32275468)
17. Peters RP, et al. Quantitative detection of Staphylococcus aureus and Enterococcus faecalis DNA in blood to diagnose bacteremia in patients in the intensive care unit. J Clin Microbiol. 2007;45(11):3641-3646. (Pubitemid 350156861)
18. Rahman Z, Esparza-Guerra L, Yap HY, Fraschini G, Bodey G, Hortobagyi G. Chemotherapy-induced neutropenia and fever in patients with metastatic breast carcinoma receiving salvage chemotherapy. Cancer. 1997;79(6):1150-1157. (Pubitemid 27118212)
19. Spiers AS, Dias SF, Lopez JA. Infection prevention in patients with cancer: microbiological evaluation of portable laminar air flow isolation, topical chlorhexidine, and oral non-absorbable antibiotics. J Hyg (Lond). 1980;84(3):457-465. (Pubitemid 10092970)
20. Schimpff SC, et al. Infection prevention in acute nonlymphocytic leukemia. Laminar air flow room reverse isolation with oral, nonabsorbable antibiotic prophylaxis. Ann Intern Med. 1975;82(3):351-358.
21. van Vliet MJ, Harmsen HJ, de Bont ES, Tissing WJ. The role of intestinal microbiota in the development and severity of chemotherapy-induced mucositis. PLoS Pathog. 2010;6(5):e1000879.
22. Fenelon LE. Protective isolation: who needs it? J Hosp Infect. 1995;30(suppl):218-222.
23. Wolach B, Gavrieli R, Pomeranz A. Effect of granulocyte and granulocyte macrophage colony stimulating factors (g-csf and gm-csf) on neonatal neutrophil functions. Pediatr Res. 2000;48(3):369-373. (Pubitemid 30637339)
24. Spiekerman K, Roesler J, Emmendoerffer A, Elsner J, Welte K. Functional features of neutrophils induced by G-CSF and GM-CSF treatment: differential effects and clinical implications. Leukemia. 1997;11(4):466-478. (Pubitemid 27173932)
25. Roilides E, Walsh TJ, Pizzo PA, Rubin M. Granulocyte colony-stimulating factor enhances the phagocytic and bactericidal activity of normal and defective human neutrophils. J Infect Dis. 1991;163(3):579-583.
26. Yang K, et al. Del- claux. Bactericidal activity response of blood neutrophils from critically ill patients to in vitro granulocyte colony-stimulating factor stimulation. Intensive Care Med. 2003;29(3):396-402. (Pubitemid 36379440)
27. Rieber N, Hector A, Kuijpers T, Roos D, Hartl D. Current concepts of hyperinflammation in chronic granulomatous disease. Clin Dev Immunol. 2012;2012:252460.
28. Wolach B, et al. Two X-linked chronic granulomatous disease patients with unusual NADPH-oxidase properties. J Clin Immunol. 2011;31(4):560-566.
29. Wolach B, Gavrieli R, Roos D, Berger-Achituv S. Lessons learned from phagocytic function studies in a large cohort of patients with recurrent infections. J Clin Immunol. 2012;32(3):454-466.
30. Hubel K, et al. Suppressed neutrophil function as a risk factor for severe infection after cytotoxic chemotherapy in patients with acute nonlym- phocytic leukemia. Ann Hematol. 1999;78(2):73-77. (Pubitemid 29132437)
31. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl. 1968;97:77-89.
32. Green JN, Winterbourn CC, Hampton MB. Analysis of neutrophil bactericidal activity. Methods Mol Biol. 2007;412(21):319-332.
33. von Mises R. Mathematical Theory Of Probability And Statistics. New York, New York, USA: Academic Press; 1964.
34. Press W, Teukolsky S, Vetterling W, Flannery B. Numerical Recipes in C. 2nd ed. Cambridge, United Kingdom: Cambridge University Press; 1992.
35. Hogg RV, Craig AT. Introduction to Mathematical Statistics. 5th ed. Upper Saddle River, New Jersey, USA: Prentice-Hall; 1995.